Triple
T4850505
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Heptares Therapeutics |
E108401
|
entity |
| Predicate | collaboratesWith |
P37
|
FINISHED |
| Object |
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
|
E474950
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69bd440a89548190a5f14ba6da6b97dc |
elicitation | completed |
| NER | batch_69bd6d1e5cf08190bd6b6a524748f170 |
ner | completed |
| NED1 | batch_69be5cdefda8819095fbc04446bf32f5 |
ned_source_triple | completed |
| NED2 | batch_69be6159ff7c8190baa116240f76dea5 |
ned_description | completed |
| NEDg | batch_69be5dadcec88190bf9a272c4a9aef9a |
nedg | completed |
Created at: March 20, 2026, 1:25 p.m.